Sign In
Buy GTLL
$0.0002
+0 (+0%)
At Close: Jun 05, 2026
NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stoc
UPPER NYACK, N.Y.--(BUSINESS WIRE)--When pharmacists can't give adult vaccinations, millions of people go without them.
TPT Global Tech Launches First Super App in the United States With VuMe Live
02:30pm, Tuesday, 25'th Feb 2025
TPT Global Tech Launches First Super App in the United States with VüMe Live SAN DIEGO, CA / ACCESS Newswire / February 25, 2025 / After seven years of development, TPT Global Tech (OTCBB:TPTW) www.t
eHealth Exchange Announces Strategic Engagement at HIMSS25 Global Conference
02:30pm, Tuesday, 25'th Feb 2025
Large Health Information Network Showcases Interoperability Advancements Using Networked FHIR Large Health Information Network Showcases Interoperability Advancements Using Networked FHIR
MILWAUKEE , Feb. 25, 2025 /PRNewswire/ -- The Ademi Firm is investigating Global Blue (NYSE: GB) for possible breaches of fiduciary duty and other violations of law in its transaction with Shift4. Cl
Tess Oxenstierna Named Investment Banker of the Year by Global M&A Network
11:15am, Tuesday, 25'th Feb 2025
Award Recognizes Outstanding Leaders and Dealmakers with Notable Impact on the Industry BOSTON , Feb. 25, 2025 /PRNewswire/ -- Capstone Partners, a leading middle market investment banking firm, is p
Levi & Korsinsky Notifies Venture Global, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - VG
11:00am, Tuesday, 25'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 25, 2025 / If you suffered a loss on your Venture Global, Inc. (NYSE:VG) investment and want to learn about a potential recovery under the federal securities
Where Will S&P Global Stock Be in 5 Years?
10:00am, Tuesday, 25'th Feb 2025
S&P Global's (SPGI 0.30%) stock has rallied more than 80% over the past five years and is currently hovering near its all-time high. The financial services leader impressed investors with its robust g
Aurora to Present at Cantor Global Technology Conference
09:00am, Tuesday, 25'th Feb 2025
PITTSBURGH--(BUSINESS WIRE)---- $AUR #aurora--Aurora Innovation, Inc. (NASDAQ: AUR) today announced David Maday, Chief Financial Officer, will participate in a fireside chat at the Cantor Global Techn
'The troubled energy transition': S&P Global's Dan Yergin on the state of energy demand
08:39am, Tuesday, 25'th Feb 2025
Dan Yergin, S&P Global vice chairman, joins 'Squawk Box' to discuss the troubled progress on energy transition, state of energy production and demand, impact of AI on energy demand, and more.
Patta Brazil Renews Global Credit Line with Sparta Commercial's Subsidiary Agoge Global USA
08:30am, Tuesday, 25'th Feb 2025
NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Sparta Commercial Services, Inc. (OTC: SRCO) ("Sparta" or the "Company"), through its subsidiary Agoge, announced the renewal of its global credit line agre
Patta Brazil Renews Global Credit Line with Sparta Commercial's Subsidiary Agoge Global USA
08:28am, Tuesday, 25'th Feb 2025
Renewal Extends Partnership to Support Import Growth and Financial Stability Key Points: NEW YORK, NY, February 25, 2025 – PRISM MediaWire – Sparta Commercial Services, Inc. (OTC: SRCO) (“Sparta
Bread Financial to Participate in the 2025 RBCCM Global Financial Institutions Conference
08:21am, Tuesday, 25'th Feb 2025
COLUMBUS, Ohio, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Bread Financial® Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending and saving
The Energy Transition Needs a Reality Check
08:00am, Tuesday, 25'th Feb 2025
Expectations of a rapid, linear transformation of the global energy system have proved misplaced. A major rethinking is in order NEW YORK , Feb. 25, 2025 /PRNewswire/ -- The energy transition will be
SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
08:00am, Tuesday, 25'th Feb 2025
SK bioscience's first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Zealand, with interim results expected by 2026 Joint R&D project between SK and CEPI includes up to
